Literature DB >> 20463001

p53 Research: the past thirty years and the next thirty years.

David Lane1, Arnold Levine.   

Abstract

Thirty years of research on the p53 family of genes has generated almost fifty thousand publications. The first of these papers detected the p53 protein associated with a viral oncogene product in transformed cells and tumors and focused the field on cancer biology. Subsequent manuscripts have shown a wide variety of functions for the p53 family of genes and their proteins. These proteins are involved in reproduction, genomic repair, fidelity and recombination, the regulation of metabolic processes, longevity, surveillance of the stability of development, the production of stem cells and changes in epigenetic marks, the development of the nervous system (p73), the immune system (p73) and skin (p63), as well as the better known roles for the family in tumor suppression. The p53 family of genes has been found in the modern day ancestors of organisms with over one billion years of evolutionary history where they play a role in germ-line fidelity over that time span. As the body plan of the vertebrates emerged with the regeneration of tissues by stem cells over a lifetime, the p53 gene and its protein were adapted to be a tumor suppressor of somatic stem and progenitor cells complementing its' past functions in the germ line. Because the p53 family of genes has played a role in germ-line fidelity and preservation of the species, even in times of stress, these genes have been under constant selection pressure to change and adapt to new situations. This has given rise to this diversity of functions all working to preserve homeostatic processes that permit growth and reproduction in a world that is constantly challenging the fidelity of information transfer at each generation. The p53 family of gene products has influenced the rates of evolutionary change, just as evolutionary changes have altered the p53 family and its functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463001      PMCID: PMC2982174          DOI: 10.1101/cshperspect.a000893

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  68 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.

Authors:  Wenwei Hu; Zhaohui Feng; Lan Ma; John Wagner; J Jeremy Rice; Gustavo Stolovitzky; Arnold J Levine
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

3.  P53 mutations in lymphomas: position matters.

Authors:  Arnold J Levine; Evan Vosburgh
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

Review 4.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 5.  p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.

Authors:  Zhaohui Feng
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

6.  A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13.

Authors:  A J Muller; A K Teresky; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  Gain of function mutations in p53.

Authors:  D Dittmer; S Pati; G Zambetti; S Chu; A K Teresky; M Moore; C Finlay; A J Levine
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

9.  Stem cells: The promises and perils of p53.

Authors:  Valery Krizhanovsky; Scott W Lowe
Journal:  Nature       Date:  2009-08-27       Impact factor: 49.962

10.  Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Authors:  D Wolf; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  176 in total

Review 1.  Crosstalk between the DNA damage response pathway and microRNAs.

Authors:  Cecil Han; Guohui Wan; Robert R Langley; Xinna Zhang; Xiongbin Lu
Journal:  Cell Mol Life Sci       Date:  2012-03-20       Impact factor: 9.261

2.  p53 in stem cells.

Authors:  Valeriya Solozobova; Christine Blattner
Journal:  World J Biol Chem       Date:  2011-09-26

3.  Tunneling nanotube (TNT) formation is independent of p53 expression.

Authors:  V Andresen; X Wang; S Ghimire; M Omsland; B T Gjertsen; H H Gerdes
Journal:  Cell Death Differ       Date:  2013-06-14       Impact factor: 15.828

Review 4.  Replicating damaged DNA in eukaryotes.

Authors:  Nimrat Chatterjee; Wolfram Siede
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

5.  DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected].

Authors:  Federica Polato; Paolo Rusconi; Stefano Zangrossi; Federica Morelli; Mattia Boeri; Alberto Musi; Sergio Marchini; Vittoria Castiglioni; Eugenio Scanziani; Valter Torri; Massimo Broggini
Journal:  J Natl Cancer Inst       Date:  2014-03-20       Impact factor: 13.506

6.  Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.

Authors:  Sue Haupt; Catherine Mitchell; Vincent Corneille; Jake Shortt; Stephen Fox; Pier Paolo Pandolfi; Mireia Castillo-Martin; Dennis M Bonal; Carlos Cordon-Cardo; Guillermina Lozano; Ygal Haupt
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

Review 7.  TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.

Authors:  Ge Zhou; Zhiyi Liu; Jeffrey N Myers
Journal:  J Cell Biochem       Date:  2016-06-03       Impact factor: 4.429

8.  Research highlights on a notable retrovirus and a popular guardian gene.

Authors:  Paraskevi Vogiatzi; Philip J Mason
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

9.  Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.

Authors:  Yiwei Zhang; Xin Zhang; Hua Lu
Journal:  Dev Biol       Date:  2014-09-28       Impact factor: 3.582

Review 10.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.